Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Secondary antiphospholipid syndrome"'
Publikováno v:
Clinical Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)
Key clinical message Neuromyelitis optica spectrum disorder is an autoimmune disease, rarely presents with antiphospholipid syndrome. Diagnosis and management of NMOSD are challenging in the background of diverse presentations, especially in resource
Externí odkaz:
https://doaj.org/article/024acbf9417a4d77a862cd1bcb782100
Autor:
Frontiers Production Office
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/9803ab8a990b46bea156ee4ba52d9559
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectivePatients with antiphospholipid syndrome (APS) have immune cell abnormalities that remain poorly understood. This study compared primary APS (PAPS) and secondary APS (SAPS) patients with healthy controls with respect to peripheral blood lymph
Externí odkaz:
https://doaj.org/article/16e766b65d014812a9fc0e96e22614ae
Autor:
Lazovic Biljana, Zlatkovic-Svenda Mirjana, Blazic Ivana, Kovac Jelena, Detanac S. Dzemail, Milic Rade, Sarac Sanja, Deatanac A. Dzenana, Zugic Vladimir
Publikováno v:
Sanamed, Vol 14, Iss 3, Pp 287-290 (2019)
Abstract: Introduction: Secondary antiphospholipid syndrome (SAPS) is APS that occurs in the context of another medical condition. Although antiphospholipid antibodies (aPL) can occur in patients with viral, bacterial, or protozoal infections, they a
Externí odkaz:
https://doaj.org/article/59f188dfd93c4f5189065331d220c3b7
Publikováno v:
BMC Pregnancy and Childbirth, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background We aimed to systematically compare arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus (SLE), primary anti-phospholipid syndrome (PAPS) and secondary anti-phospholipid syndrome
Externí odkaz:
https://doaj.org/article/9150a464db5b4fa5a89066215a003a81
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Antiphospholipid syndrome (APS) is a multisystem autoimmune disease most commonly associated with recurrent arterial and venous thromboembolism and recurrent fetal loss. Other possible antiphospholipid antibody (aPL)-related clinical manifestations i
Externí odkaz:
https://doaj.org/article/e64796c333e649c590161aca85871eb7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vladimir Zugic, Mirjana Zlatkovic-Svenda, Dzemail S Detanac, Jelena Kovac, Dzenana A Detanac, Sanja Sarac, Ivana Blazic, Biljana Lazovic, Rade Milic
Publikováno v:
Sanamed, Vol 14, Iss 3, Pp 287-290 (2019)
Introduction: Secondary antiphospholipid syndrome (SAPS) is APS that occurs in the context of another medical condition. Although antiphospholipid antibodies (aPL) can occur in patients with viral, bacterial, or protozoal infections, they are rarely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4a90976e0d1a01e44a24ce1e799c83
https://doi.org/10.24125/sanamed.v14i3.365
https://doi.org/10.24125/sanamed.v14i3.365
Autor:
Omneya M. Osman, Diana Nagy, Noha M. Hosny Shaheen, Taghrid Gaafar, Heba M. Selim, Mai M. Sherif, Salma Mohamed Saed, Hala Ahmed Raafat Youssef
Publikováno v:
Egyptian Rheumatologist, Vol 42, Iss 3, Pp 201-206 (2020)
Background: MicroRNAs (miRs) are noncoding gene regulators that may have a role as diagnostic or prognostic biomarkers in systemic lupus erythematosus (SLE) and its complications. SLE is an autoimmune disease that may be associated with secondary ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac048566f50d994df94b2e604c25f52
https://doi.org/10.1016/j.ejr.2020.05.002
https://doi.org/10.1016/j.ejr.2020.05.002
Publikováno v:
JCR: Journal of Clinical Rheumatology. 27:e297-e301
BACKGROUND Diffuse alveolar hemorrhage (DAH) occurs in patients with both primary and secondary antiphospholipid antibody syndrome (APS). We sought to determine the differences in clinical presentation, management, and outcomes of DAH in these patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f97b5faf356c649f31c75e6cec339ceb
https://doi.org/10.1097/rhu.0000000000001358
https://doi.org/10.1097/rhu.0000000000001358